XRCC2 and non-small cell lung carcinoma: In accordance with other studies which demonstrated a role of homologous recombination (HR) in inter-strand crosslink tolerance [19], we observed an 8-fold up-regulation of XRCC2 in cisplatin-refractory NSCLC clones.